Kestra Advisory Services’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-41,570	Closed	-$193K	–	2160
2022 Q1	$193K	Buy	41,570 +8,870	+27%	+$41.2K	﹤0.01%	1861
2021 Q4	$164K	Buy	+32,700	New	+$164K	﹤0.01%	1901